Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Controlled Trial to Evaluate the Safety and Effectiveness of the TearCare® System in the Treatment of the Signs and Symptoms of Dry Eye Disease

NCT03857919 is registered in ClinicalTrials.gov with Sight Sciences, Inc. as lead sponsor.

NCT NCT03857919
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03857919 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Controlled Trial to Evaluate the Safety and Effectiveness of the TearCare® System in the Treatment of the Signs and Symptoms of Dry Eye Disease
Lead sponsor
Sight Sciences, Inc.
Phase
Not applicable
Overall status
Completed
Start date
March 3, 2019
Completion date
December 18, 2020
Enrollment
235 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye, meibomian gland dysfunction